Evidence map›Paper›PMID 40225935›Full record

SynthesisHuman mutation2024

Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.

Anastasia Ward, Ramil Mauleon, Chee Y Ooi, Nedeljka Rosic

Abstract readSystematic Review
In one paragraph

Synthesis in Human mutation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anastasia WardFaculty of Health, Southern Cross University, Coolangatta, Gold Coast, Queensland, Australia.ORCID 0000-0002-6597-934X
Ramil MauleonFaculty of Health, Southern Cross University, Coolangatta, Gold Coast, Queensland, Australia.ORCID 0000-0001-8512-144X
Chee Y OoiSchool of Clinical Medicine, Discipline of Paediatrics & Child Health, Randwick Clinical Campus, UNSW Medicine & Health, UNSW, Sydney, Australia.ORCID 0000-0001-7111-0926
Nedeljka RosicFaculty of Health, Southern Cross University, Coolangatta, Gold Coast, Queensland, Australia.ORCID 0000-0002-2598-7046

Funding

Medical Research Council
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a complex monogenic disorder with a large variability in disease severity. Growing evidence suggests that the variation observed depends not only on variations in the cystic fibrosis transmembrane conductance regulator (

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGenes, ModifierGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhenotypeCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCFTRcystic fibrosisgene expressiongenomic variationsmodifier genesphenotypeseverity

Identifiers

PMID40225935
PMCPMC11919198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.